22 déc. 2020 - Phase III clinical trials were completed
Description:
Phase III clinical trials were completed in December 2020; the vaccine had not been licensed for prophylactic use against COVID-19, although the Moderna and Pfizer COVID-19 vaccines had been approved for marketing under emergency use authorizations from the FDA and regulatory agencies in other countriesAjouté au bande de temps:
Date:
22 déc. 2020
Maintenaint
~ Il y a 4 ans et 9 mois